160 related articles for article (PubMed ID: 24748657)
1. Desensitization of functional µ-opioid receptors increases agonist off-rate.
Williams JT
Mol Pharmacol; 2014 Jul; 86(1):52-61. PubMed ID: 24748657
[TBL] [Abstract][Full Text] [Related]
2. Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization.
Virk MS; Williams JT
Mol Pharmacol; 2008 Apr; 73(4):1301-8. PubMed ID: 18198283
[TBL] [Abstract][Full Text] [Related]
3. Differential Desensitization Observed at Multiple Effectors of Somatic μ-Opioid Receptors Underlies Sustained Agonist-Mediated Inhibition of Proopiomelanocortin Neuron Activity.
Fox PD; Hentges ST
J Neurosci; 2017 Sep; 37(36):8667-8677. PubMed ID: 28821664
[TBL] [Abstract][Full Text] [Related]
4. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
Kovoor A; Celver JP; Wu A; Chavkin C
Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514
[TBL] [Abstract][Full Text] [Related]
5. Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide mu-opioid receptor agonists.
Blanchet C; Sollini M; Lüscher C
Mol Cell Neurosci; 2003 Oct; 24(2):517-23. PubMed ID: 14572471
[TBL] [Abstract][Full Text] [Related]
6. Tolerance to repeated morphine administration is associated with increased potency of opioid agonists.
Ingram SL; Macey TA; Fossum EN; Morgan MM
Neuropsychopharmacology; 2008 Sep; 33(10):2494-504. PubMed ID: 18046309
[TBL] [Abstract][Full Text] [Related]
7. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
8. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization.
Virk MS; Arttamangkul S; Birdsong WT; Williams JT
J Neurosci; 2009 Jun; 29(22):7341-8. PubMed ID: 19494155
[TBL] [Abstract][Full Text] [Related]
10. Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes.
Celver JP; Lowe J; Kovoor A; Gurevich VV; Chavkin C
J Biol Chem; 2001 Feb; 276(7):4894-900. PubMed ID: 11060299
[TBL] [Abstract][Full Text] [Related]
11. Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes.
Kobayashi T; Ikeda K; Kumanishi T
Br J Pharmacol; 1998 Feb; 123(3):421-6. PubMed ID: 9504382
[TBL] [Abstract][Full Text] [Related]
12. Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure.
Birdsong WT; Arttamangkul S; Clark MJ; Cheng K; Rice KC; Traynor JR; Williams JT
J Neurosci; 2013 Feb; 33(9):4118-27. PubMed ID: 23447620
[TBL] [Abstract][Full Text] [Related]
13. kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes.
Ma GH; Miller RJ; Kuznetsov A; Philipson LH
Mol Pharmacol; 1995 May; 47(5):1035-40. PubMed ID: 7746270
[TBL] [Abstract][Full Text] [Related]
14. Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes.
Kovoor A; Nappey V; Kieffer BL; Chavkin C
J Biol Chem; 1997 Oct; 272(44):27605-11. PubMed ID: 9346897
[TBL] [Abstract][Full Text] [Related]
15. Caged naloxone reveals opioid signaling deactivation kinetics.
Banghart MR; Williams JT; Shah RC; Lavis LD; Sabatini BL
Mol Pharmacol; 2013 Nov; 84(5):687-95. PubMed ID: 23960100
[TBL] [Abstract][Full Text] [Related]
16. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR
Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353
[TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):585-93. PubMed ID: 9930730
[TBL] [Abstract][Full Text] [Related]
18. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the cloned kappa and mu opioid receptors.
Tallent M; Dichter MA; Reisine T
Neuroscience; 1998 Aug; 85(3):873-85. PubMed ID: 9639280
[TBL] [Abstract][Full Text] [Related]
20. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
